Skip to content

GILEAD SCIENCES, INC.: LKFT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILEAD SCIENCES, INC. on LKFT, newest first. How the timeline and the estimate are built.

GILEAD SCIENCES, INC. held 16,707,477 LKFT shares at 2026-09-30 per its 13F-HR filed 2026-11-06.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    34.24% of the 13F portfolio, value $501,284,604.

    13F-HR 0001123292-26-001479 filed by GILEAD SCIENCES, INC.
    Accepted , ingested

  2. period ended2026-06-30
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    30.34% of the 13F portfolio, value $500,157,715.

    13F-HR 0001123292-26-001034 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    23.67% of the 13F portfolio, value $501,224,310.

    13F-HR 0001123292-26-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    28.45% of the 13F portfolio, value $550,616,290.

    13F-HR 0001123292-26-000164 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    32.31% of the 13F portfolio, value $578,747,003.

    13F-HR 0001123292-25-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    36.53% of the 13F portfolio, value $467,642,281.

    13F-HR 0001123292-25-000364 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 16,707,477 shares
    Change vs previous 13F 0 shares

    35.5% of the 13F portfolio, value $419,394,293.

    13F-HR 0001123292-25-000217 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 16,707,477 shares
    Change vs previous 13F not available

    29.77% of the 13F portfolio, value $461,727,194.

    13F-HR 0001123292-25-000079 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).